美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

猴痘概念

1,550.57

-1.2322-0.08%

涨家数：7

跌家数：5

平家数：- -

市盈率：- -

高：1,562.48

开：1,551.79

低：1,540.01

收：1,551.80

数据加载中...

总览新闻资讯

BUZZ-Viatris 盈利预测低于预期，创一年多新低

Chimerix, Inc.盘中异动早盘大幅上涨5.00%

e家快服盘中异动早盘股价大跌5.26%

伊诺维奥制药盘中异动早盘急速上涨5.05%

晖致盘中异动股价大跌17.62%

印度工厂进口受限，制药商 Viatris 预计 2025 年业绩疲软

BUZZ-Viatris 盈利预测低于预期，业绩下滑

e家快服盘中异动股价大跌5.14%报0.552美元

Chimerix, Inc.盘中异动早盘急速上涨5.35%报4.92美元

伊诺维奥制药盘中异动股价大跌5.45%报1.91美元

Applied Dna Sciences, Inc.盘中异动急速下跌6.85%报0.146美元

Geovax Labs, Inc.盘中异动股价大跌5.23%

困境Biotech这就不收购了？

吉利德(GILD.US)突破性长效HIV疗法在欧洲获得加速审评

Emergent Biosolutions Inc.盘中异动急速跳水5.19%报7.31美元

Chimerix, Inc.盘中异动早盘股价大跌5.24%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4583/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4583"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"猴痘概念","latestPrice":1550.5687,"timestamp":1741291998976,"preClose":1551.8009,"halted":0,"volume":41412514,"delay":0,"changeRate":-0.000794,"change":-1.232178,"pbRate":3.824438,"amount":976623799.029034,"amplitude":0.014477,"prevYearClose":1284.7982,"fiveDayClose":1511.4258,"twentyDayClose":1385.6759,"turnoverRate":0.014753,"marketCap":175670127175,"floatMarketCap":174881738588.5,"peRate":756.174276},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","high":1562.48,"amplitude":0.014477,"preClose":1551.8009,"low":1540.0138,"pbRate":"3.824438","latestPrice":1550.5687,"volume":41412514,"delay":0,"open":1551.7856,"prevYearClose":1284.7982,"prevWeekClose":1535.672,"prevMonthClose":1535.672,"prevQuarterClose":1284.7982,"fiveDayClose":1511.4258,"twentyDayClose":1385.6759,"sixtyDayClose":1305.8654,"secType":"PLATE","market":"US","turnoverRate":0.014753,"peRate":756.174276,"marketCap":175670127175,"floatMarketCap":174881738588.5,"timestamp":1741291998976,"nameCN":"猴痘概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4583\",,,,undefined,":{"bkCode":"BK4583","up":7,"down":5,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4583\",pageSize:16,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514033644","title":"BUZZ-Viatris 盈利预测低于预期，创一年多新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2514033644","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514033644?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 02:40","pubTimestamp":1740681605,"startTime":"0","endTime":"0","summary":"** VTRS表示，预计FDA的行动将对其2025年的总收入产生约5亿美元的负面影响，调整后的核心利润约为3.85亿美元。** 去年，由于违反监管规定，FDA 已限制  从 Viatris 位于印度印多尔的工厂进口。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3T3PI21I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTRS","BK4007","BK4588","BK4585","BK4583","LU2087621335.USD","LU1839511570.USD"],"gpt_icon":0},{"id":"2514538121","title":"Chimerix, Inc.盘中异动 早盘大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514538121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514538121?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 23:11","pubTimestamp":1740669106,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时11分，Chimerix, Inc.股票出现波动，股价急速拉升5.00%。Chimerix, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Quoin Pharmaceuticals Ltd、Alpha Tau Medical Ltd C/Wts 、Editas Medicine, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为705.66%、106.54%、102.13%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Quoin Pharmaceuticals Ltd，振幅分别为78.88%、43.51%、34.80%。Chimerix, Inc.公司简介：Chimerix Inc.是一家总部位于美国的生物制药公司，从事药物的研究，开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231147abdf795f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231147abdf795f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","CMRX","BK4139"],"gpt_icon":0},{"id":"2514389262","title":"e家快服盘中异动 早盘股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514389262?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 23:04","pubTimestamp":1740668699,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时04分，e家快服股票出现波动，股价急速跳水5.26%。截至发稿，该股报0.540美元/股，成交量4.3357万股，换手率0.50%，振幅6.47%。e家快服股票所在的消费者服务行业中，整体跌幅为0.71%。其相关个股中，Interactive Strength Inc.、慧优体、Click Holdings Limited涨幅较大，Interactive Strength Inc.、慧优体、e家快服较为活跃，换手率分别为6943.21%、0.91%、0.52%，振幅较大的相关个股有Interactive Strength Inc.、Frontdoor, Inc.、慧优体，振幅分别为64.00%、9.26%、8.96%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227230459a2568282&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227230459a2568282&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4192","BK4539","EJH","BK4583"],"gpt_icon":0},{"id":"2514857133","title":"伊诺维奥制药盘中异动 早盘急速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514857133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514857133?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 22:47","pubTimestamp":1740667654,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时47分，伊诺维奥制药股票出现波动，股价急速拉升5.05%。截至发稿，该股报2.08美元/股，成交量5.7309万股，换手率0.16%，振幅4.80%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.80%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的活性免疫疗法和疫苗，以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224734a2567e46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224734a2567e46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INO","BK4139","BK4583","BK4568"],"gpt_icon":0},{"id":"2514854013","title":"晖致盘中异动 股价大跌17.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514854013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514854013?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 22:30","pubTimestamp":1740666604,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时30分，晖致股票出现异动，股价快速下跌17.62%。截至发稿，该股报9.26美元/股，成交量222.466万股，换手率0.19%，振幅0.00%。晖致股票所在的制药行业中，整体涨幅为0.00%。通过强强联手，晖致医药有限公司成为世界上最大的仿制药制造商之一，为超过 165 个国家提供服务。虽然涵盖 10 多个主要治疗领域，但晖致医药有限公司已将皮肤科、眼科和胃肠科确定为未来创新的三个关键重点领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722300498950f96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722300498950f96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2087621335.USD","BK4007","BK4585","BK4588","VTRS","LU1839511570.USD","BK4583"],"gpt_icon":0},{"id":"2514780287","title":"印度工厂进口受限，制药商 Viatris 预计 2025 年业绩疲软","url":"https://stock-news.laohu8.com/highlight/detail?id=2514780287","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514780287?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 21:18","pubTimestamp":1740662318,"startTime":"0","endTime":"0","summary":"Viatris 的股票在盘前交易中下跌了 14.6%。Viatris于2024年12月23日披露，由于违反联邦要求，美国食品和药物管理局 已限制  从其位于印度印多尔 的工厂进口 11种产品。根据 LSEG 编制的数据，总部位于宾夕法尼亚州卡农斯堡的Viatris 预计 2025 年收入在 135 亿美元 至 140  亿美元之间，低于分析师预计的 142.7 亿美元。由于担心产品短缺，美国食品和药物管理局已允许 Viatris 的四种产品例外，但具体产品尚未披露。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3T3PI18P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999011175.SGD","LU0868494617.USD","LU0306806265.USD","SG9999001176.USD","LU0985481810.HKD","LU1066053197.SGD","SG9999002232.USD","IE00B19Z3581.USD","LU1894683348.USD","VTRS","LU1839511570.USD","LU0289739699.SGD","BK4581","SG9999003800.SGD","SG9999013999.USD","SGXZ57979304.SGD","LU2087621335.USD","IE00BBT3K403.USD","LU0225771236.USD","BK4585","LU1883839398.USD","LU0456855351.SGD","BK4583","BK4568","LU0306807586.USD","LU0058720904.USD","SG9999001176.SGD","BK4007","IE000M9KFDE8.USD","LU1066051498.USD","LU0321505439.SGD","LU0225284248.USD","SG9999002224.SGD","BK4588","BK4592","IE00BLSP4452.SGD","LU0170899867.USD","LU0122379950.USD","LU0234572021.USD","LU1894683264.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","IE00BLSP4239.USD","BK4599","BK4550","BK4534","LU1057294990.SGD","BK4533"],"gpt_icon":1},{"id":"2514830804","title":"BUZZ-Viatris 盈利预测低于预期，业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2514830804","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514830804?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 21:02","pubTimestamp":1740661352,"startTime":"0","endTime":"0","summary":"2月27日 -  ** 仿制药生产商Viatris VTRS.O股价盘前下跌11.3%至9.97美元 ** 该公司预计  2025 年收入在 135 亿至 140 亿美元之间，低于分析师估计的 142.7 亿美元 - LSEG ** 该公司预计2025年每股收益介于2.12美元至2.26美元之间，低于每股收益2.59美元的预期 - LSEG ** VTRS 表示，预计 FDA 的行动将对其 2025 年的总收入产生约 5 亿美元的负面影响，调整后的核心利润将减少约 3.85 亿美元。** 去年，由于违反监管规定，FDA 已限制  从 Viatris 位于印度印多尔的工厂进口。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3T3PI17G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2091194634.USD","LU0069063385.USD","LU0171280430.USD","LU0171293334.USD","LU0289739343.SGD","LU1228905540.USD","LU0345777659.USD","LU0887340254.USD","LU0289961442.SGD","LU2271345857.HKD","LU0158827948.USD","LU0158827781.USD","LU1355424745.HKD","BK4583","LU2089284900.SGD","LU2114397693.USD","LU1153584641.USD","BK4588","IE00BQXX3F31.USD","LU1839511570.USD","LU2087621335.USD","LU1078025761.USD","LU0969580561.USD","IE00BQXX3C00.GBP","LU0511384066.AUD","LU0057025933.USD","LU2023251221.USD","LU0289960550.SGD","LU0963555726.SGD","LU1051770623.HKD","LSEG.UK","LU1003076772.USD","LU1228905037.USD","LU2089283258.USD","VTRS","LU0526926950.USD","LU2028103732.USD","IE00BKPKM643.USD","LU0345777147.USD","LU1019632923.USD","LU0171276677.USD","BK4007","LU0472753341.HKD","LU1019634622.SGD","LU0545562505.USD","IE00BQXX3D17.EUR","LU2111349929.HKD","LU0788108743.HKD","BK5051","BK4585"],"gpt_icon":0},{"id":"2514850699","title":"e家快服盘中异动 股价大跌5.14%报0.552美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514850699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514850699?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 00:26","pubTimestamp":1740587197,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时26分，e家快服股票出现波动，股价大幅下挫5.14%。截至发稿，该股报0.552美元/股，成交量16.7035万股，换手率1.92%，振幅4.88%。e家快服股票所在的消费者服务行业中，整体涨幅为0.68%。其相关个股中，Interactive Strength Inc.、Click Holdings Limited、Yy Group Holding Limited涨幅较大，Interactive Strength Inc.、e家快服、慧优体较为活跃，换手率分别为9505.88%、1.92%、1.83%，振幅较大的相关个股有Interactive Strength Inc.、Click Holdings Limited、慧优体，振幅分别为129.50%、17.70%、7.85%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270026379893c0c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270026379893c0c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4192","EJH","BK4583"],"gpt_icon":0},{"id":"2514592758","title":"Chimerix, Inc.盘中异动 早盘急速上涨5.35%报4.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514592758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514592758?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 22:45","pubTimestamp":1740581129,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时45分，Chimerix, Inc.股票出现波动，股价急速拉升5.35%。截至发稿，该股报4.92美元/股，成交量7.3417万股，换手率0.08%，振幅3.85%。Chimerix, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Chimerix, Inc.公司简介：Chimerix Inc.是一家总部位于美国的生物制药公司，从事药物的研究，开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224529abddf08a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224529abddf08a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMRX","BK4139","BK4583"],"gpt_icon":0},{"id":"2514048860","title":"伊诺维奥制药盘中异动 股价大跌5.45%报1.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514048860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514048860?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 02:28","pubTimestamp":1740508126,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日02时28分，伊诺维奥制药股票出现波动，股价快速下挫5.45%。截至发稿，该股报1.91美元/股，成交量36.2775万股，换手率1.00%，振幅6.44%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.09%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的活性免疫疗法和疫苗，以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226022846a253bdec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226022846a253bdec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","INO","BK4583"],"gpt_icon":0},{"id":"2514601660","title":"Applied Dna Sciences, Inc.盘中异动 急速下跌6.85%报0.146美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514601660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514601660?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 23:38","pubTimestamp":1740497913,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时38分，Applied Dna Sciences, Inc.股票出现波动，股价急速下跌6.85%。Applied Dna Sciences, Inc.股票所在的生命科学行业中，整体涨幅为0.00%。Applied Dna Sciences, Inc.公司简介：Applied DNA Sciences Inc 是一家开发和商业化生产和检测脱氧核糖核酸和核糖核酸技术的生物技术公司。该公司以Applied DNA Sciences、SigNature分子标签、SigNature T分子标签、fiberTyping、SigNify等品牌提供的产品和服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233833abdc8f2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233833abdc8f2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4583","RNA","BK4139","BK4585","DNA","BK4588","BK4109","BK4121","APDN"],"gpt_icon":0},{"id":"2514018209","title":"Geovax Labs, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514018209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514018209?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 23:04","pubTimestamp":1740495879,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时04分，Geovax Labs, Inc.股票出现异动，股价快速下跌5.23%。截至发稿，该股报1.45美元/股，成交量5.4942万股，换手率0.58%，振幅8.01%。Geovax Labs, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。Geovax Labs, Inc.公司简介：Geovax Labs Inc 是一家临床阶段的生物技术公司，利用新型专有平台开发针对传染病和实体瘤癌症的人类疫苗和免疫疗法。GeoVax 的产品线包括正在进行的下一代 COVID-19疫苗的人体临床试验和针对头颈癌的基因导向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523044098925452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523044098925452&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOVX","BK4139","BK4583"],"gpt_icon":0},{"id":"2514698690","title":"困境Biotech这就不收购了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2514698690","media":"谈思生物","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514698690?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 15:21","pubTimestamp":1740468100,"startTime":"0","endTime":"0","summary":"2025.02.25本文字数：995，阅读时长大约3分钟导读：HOOKIPA Pharma因研发管线受挫、罗氏终止合作及投资机构信心不足，曾计划收购Poolbeg Pharma以拓展业务，但近期因资金状况改善而终止收购。然而，鉴于CAR-T市场增长放缓及Poolbeg核心产品POLB 001市场前景存疑，收购的必要性受到质疑。然而，最近HOOKIPA Pharma宣布终止收购计划。在这种背景下，即便HOOKIPA Pharma完成了对Poolbeg Pharma的收购，吉利德也未必会将Poolbeg的POLB 001纳入其开发计划。从这个角度来说，收购Poolbeg Pharma可能并不是一个明智的选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225175634abdc338d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225175634abdc338d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4022","IE00B19Z3581.USD","LU0234570918.USD","LU1585245621.USD","GILD","LU1839511570.USD","IE00B3T34201.USD","LU2087621335.USD","LU0289739699.SGD","LU1430594728.SGD","LU2089984988.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","IE0002270589.USD","BK4139","CAR","BK4588","BK4230","LU2468319806.SGD","BK4583","IE00B7SZLL34.SGD","LU0320765992.SGD","LU1066051498.USD","IE00BSNM7G36.USD","LU1066053197.SGD","BK4585","BK4550","BK4532","IE00B19Z3B42.SGD","LU1571399168.USD","BK4568","IE00BKVL7J92.USD","LU0889565916.HKD","BK4566","BK4578","LU0109394709.USD"],"gpt_icon":0},{"id":"2514304620","title":"吉利德(GILD.US)突破性长效HIV疗法在欧洲获得加速审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2514304620","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514304620?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 14:30","pubTimestamp":1740465038,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，吉利德科学公司今日宣布，欧洲药品管理局接受该公司为lenacapavir递交的上市许可申请，每半年注射一次，作为HIV感染的暴露前预防疗法。EMA人用药品委员会认为，每半年一次用于预防HIV感染的lenacapavir在公共卫生和治疗创新方面具有重大意义，上市申请将按加速审评时间表进行评估。在PURPOSE 2中，lenacapavir治疗组中99.9%的受试者未感染HIV，与背景HIV感染率相比，感染风险降低96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253915.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BSNM7G36.USD","LU1430594728.SGD","LU2468319806.SGD","IE00B3T34201.USD","BK4585","BK4566","BK4583","LU0889565916.HKD","BK4588","LU1571399168.USD","BK4139","BK4532","BK4568","LU0234570918.USD","LU2087621335.USD","GILD","IE00BKVL7J92.USD","LU0109394709.USD","IE00BZ1G4Q59.USD","LU1066053197.SGD","IE00B19Z3581.USD","BK4578","LU1585245621.USD","LU1839511570.USD","LU0289739699.SGD","LU2089984988.USD","IE0002270589.USD","LU0320765992.SGD","LU0058720904.USD","BK4550","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU1066051498.USD"],"gpt_icon":0},{"id":"2513781327","title":"Emergent Biosolutions Inc.盘中异动 急速跳水5.19%报7.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513781327","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513781327?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 23:28","pubTimestamp":1740410881,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时28分，Emergent Biosolutions Inc.股票出现异动，股价大幅下挫5.19%。截至发稿，该股报7.31美元/股，成交量32.9475万股，换手率0.61%，振幅4.86%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为0.75%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242328039891035c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242328039891035c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4583","EBS"],"gpt_icon":0},{"id":"2513783007","title":"Chimerix, Inc.盘中异动 早盘股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513783007","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513783007?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 23:04","pubTimestamp":1740409497,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时04分，Chimerix, Inc.股票出现波动，股价大幅跳水5.24%。截至发稿，该股报4.88美元/股，成交量45.3882万股，换手率0.50%，振幅5.41%。Chimerix, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Chimerix, Inc.公司简介：Chimerix Inc.是一家总部位于美国的生物制药公司，从事药物的研究，开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242304579890fe16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242304579890fe16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","CMRX","BK4139"],"gpt_icon":0}],"pageSize":16,"totalPage":4,"pageCount":3,"totalSize":55}]}}